Increased understanding of UBE4B targets and downstream signaling pathways will help identify the functional links between UBE4B expression and patient outcomes and identify novel targets for the development of new treatment combinations for children with neuroblastoma. This evidence concerns the gene UBE4B and neuroblastoma.